How Many People Suffer From Sleep Apnea? Key Stats

An estimated 936 million adults worldwide have obstructive sleep apnea, making it one of the most common chronic conditions on the planet. That figure, drawn from a landmark 2019 analysis in The Lancet Respiratory Medicine, means roughly one in every eight adults is affected. In the United States alone, prevalence estimates range widely depending on the diagnostic threshold used, but the numbers are consistently staggering. Perhaps most striking: approximately 80% of cases remain undiagnosed.

Prevalence by Age and Sex

Sleep apnea does not affect everyone equally. Men are significantly more likely to have it than women, and the gap is widest in younger age groups. A 2017 systematic review found that 13% to 33% of adult men and 6% to 19% of adult women meet the diagnostic threshold of five or more breathing disruptions per hour of sleep.

Age is the other major driver. A large U.S. study analyzing over 12 million recorded nights of sleep from more than 38,000 participants found dramatic increases with age, even among people at a normal weight. For women under 50 with a healthy BMI, just 2.8% had sleep apnea. For women 50 and older, that jumped to 16.1%. Among men, the pattern was even more pronounced: 11.2% of normal-weight men under 50 had sleep apnea, compared to 37.5% of normal-weight men 50 and older. That means more than one in three older men at a healthy weight still qualifies for a diagnosis.

These numbers climb further when you include people who are overweight or obese, since excess weight is the single strongest modifiable risk factor. Fatty tissue in and around the throat narrows the airway, making collapse during sleep more likely.

Why 80% of Cases Go Undiagnosed

The sheer size of the undiagnosed population is one of the defining features of this condition. Most people with sleep apnea don’t know they have it. They may attribute their daytime fatigue to stress, aging, or poor sleep habits. Bed partners sometimes notice loud snoring or gasping, but many people sleep alone or dismiss these signs as normal.

Traditional diagnosis requires an overnight sleep study, either in a lab or at home with a portable monitor. That barrier, combined with low awareness, means the vast majority of affected people have never been tested. This matters because untreated sleep apnea carries real health consequences that accumulate over years.

The Cardiovascular Connection

Sleep apnea and heart disease overlap to a degree that surprises most people. According to a scientific statement from the American Heart Association, sleep apnea is present in 40% to 80% of patients with hypertension, heart failure, coronary artery disease, atrial fibrillation, and stroke. Among people with resistant hypertension (high blood pressure that doesn’t respond well to medication), up to 80% have sleep apnea.

The mechanism is straightforward. Each time your airway collapses during sleep, your blood oxygen drops, your body releases stress hormones, and your blood pressure spikes. This can happen dozens or even hundreds of times per night. Over months and years, that repeated stress damages blood vessels, raises baseline blood pressure, and promotes inflammation throughout the cardiovascular system.

Mortality Risk With Severe Cases

Untreated severe sleep apnea is associated with a substantially higher risk of death. Research published in the European Respiratory Journal found that men with severe sleep apnea had roughly 2.5 times the risk of dying from any cause compared to men without the condition, even after adjusting for age and body weight. Men with moderately severe cases still faced about double the mortality risk.

These numbers reflect the cumulative toll of years of disrupted sleep and oxygen deprivation. The risk is highest in younger and middle-aged adults, likely because other age-related health problems begin to dominate mortality statistics in older populations.

The Economic Burden

The American Academy of Sleep Medicine estimates that undiagnosed sleep apnea cost the United States approximately $149.6 billion in a single year. That figure accounts for lost workplace productivity, motor vehicle accidents caused by drowsy driving, and the healthcare costs of treating conditions that worsen when sleep apnea goes unmanaged, particularly heart disease, stroke, and diabetes. Treating sleep apnea is far less expensive than treating its consequences.

Children Are Affected Too

Sleep apnea is not limited to adults. In children, the most common cause is enlarged tonsils and adenoids, which can physically block the airway during sleep. Children with Down syndrome, craniofacial conditions like Pierre Robin sequence, neuromuscular disorders, and obesity face higher risk. Unlike adults, children with sleep apnea often show behavioral symptoms rather than obvious sleepiness: hyperactivity, difficulty concentrating, and irritability that can mimic attention deficit disorders. Removal of the tonsils and adenoids resolves the condition in most pediatric cases.

Who Should Pay Attention

Certain groups carry disproportionately high risk. You’re more likely to have sleep apnea if you are male, over 50, carry excess weight (especially around the neck), have a family history of the condition, or have a naturally narrow airway. Smoking, alcohol use before bed, and nasal congestion also increase risk. Postmenopausal women see a significant jump in prevalence, likely because the hormonal changes that occur after menopause affect muscle tone in the upper airway.

The hallmark symptoms are loud, chronic snoring, episodes of gasping or choking during sleep (often noticed by a partner), and persistent daytime sleepiness that doesn’t improve with more time in bed. Morning headaches, dry mouth upon waking, and difficulty concentrating are also common. If you recognize this pattern, a home sleep test is now widely available and far simpler than the traditional overnight lab study. Given that four out of five cases remain undetected, the odds that someone reading this article has undiagnosed sleep apnea are not small.